LicianPro

PROK stock

ProKidney Corp. (PROK) stock news · rev $893.0K

ProKidney Corp. (PROK) is a biotechnology company listed on US.

This PROK news page leads with what ProKidney Corp. filed — not a scraped headline mill.

No cached 8-K sentence for PROK yet. We will not pad this page with generic market recap.

Latest reported PROK revenue for 2025-12-31 was $893.0K. Net income was -$69.0M. Revenue was up 1075.0% from 2024-12-31 to 2025-12-31. PROK currently screens at market cap $543.7M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the PROK stock page; for the tape open the quote page.

PROK stock news FAQ

What are PROK's latest revenue and net income?

Latest cached ProKidney Corp. (PROK) revenue for Dec 31, 2025 was $893.0K. Net income was -$69.0M. Statements: https://lician.com/financials/prok

How did PROK revenue change from the prior cached period?

Cached ProKidney Corp. (PROK) revenue was up 1075.0% from $76.0K (Dec 31, 2024) to $893.0K (Dec 31, 2025). Statements: https://lician.com/financials/prok

What is PROK's market cap?

ProKidney Corp. (PROK) market cap is $543.7M on the latest cached fundamentals snapshot.

What kind of company is PROK?

ProKidney Corp. (PROK) is a biotechnology company listed on US.

Where is PROK stock news listed?

Cached stock news for ProKidney Corp. (PROK) is listed at https://lician.com/news/prok. Filings: https://lician.com/sec/prok

Not investment advice.

Full PROK analysis